Dear colleagues, Further to the save the date for this event, previously circulated, please find attached the agenda for the UK BMT Pharmacists Group Hybrid Educational Meeting, taking place on…
A global community of oncology pharmacy practitioners striving to advance cancer care Please support the Symposium by attending plenary sessions, asking questions to the live speakers, joining in the…
Dear BOPA Members As the Chair of the British Oncology Pharmacy Association (BOPA), I am writing to ask you to consider supporting Joseph Williams in the upcoming Royal Pharmaceutical Society English Pharmacy Advisory Council (currently called…
Monday 23rd February 2026 at 12:00 GMT REGISTER for the Webinar HERE Available for both PAID members and FREE associates The BOPA Education and Training Subcommittee would like to invite you…
SAVE THE DATE The 29th British Oncology Pharmacy Association (BOPA) Annual Conference 📅 2–4 October 2026 📍 ICC London Olympia We are delighted to share an important date for your diaries: The…
UK Board publishes collaborative proposals for the future of pharmacy professional leadership as part of the Royal College of Pharmacy The UK Pharmacy Professional Leadership Advisory Board has today published…
We’re delighted to share that the BOPA abstracts presented at the 28th Annual BOPA Conference have now been published in the Journal of Oncology Pharmacy Practice. Huge congratulations to everyone…
Open Letter to UK Pharmacists, Pharmacy Technicians and Pharmacy Trainees and Students Through an open letter published on its website, the UK Pharmacy Professional Leadership Advisory Board is inviting…
As we head into 2026, BOPA is really pleased to share that the credentialing webinar support series from BOPA will continue in 2026. Through ongoing membership feedback, we’ve clearly identified…
17th December 2025 13:00-14:00 GMT REGISTER for the Webinar HERE Available for both PAID members and FREE associates The BOPA Education and Training Subcommittee would like to invite you to one…
IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…
The BOPA Immunotherapy Cancer Advisory Group, have recently done some research into immune-related cardiac toxicity; both the monitoring for, and management of, these rare but serious adverse effects. Simon Jenkinson,…
